Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-02-01 @ 4:32 PM
Study NCT ID:
NCT01523093
Status:
COMPLETED
Last Update Posted:
2012-02-09
First Post:
2012-01-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions
Sponsor:
Ranbaxy Laboratories Limited
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |
Keywords: